Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 85 entries
Sorted by: Best Match Show Resources per page
Does cytochrome P450 liver isoenzyme induction increase the risk of liver toxicity after paracetamol overdose?.

Open access emergency medicine : OAEM

Kalsi SS, Wood DM, Waring WS, Dargan PI.
PMID: 27147854
Open Access Emerg Med. 2011 Oct 13;3:69-76. doi: 10.2147/OAEM.S24962. eCollection 2011.

Paracetamol (acetaminophen, N-acetyl-p-aminophenol, 4-hydroxyacetanilide) is the most common cause of acute liver failure in developed countries. There are a number of factors which potentially impact on the risk of an individual developing hepatotoxicity following an acute paracetamol overdose. These...

Cite
Kalsi SS, Wood DM, Waring WS, et al. Does cytochrome P450 liver isoenzyme induction increase the risk of liver toxicity after paracetamol overdose?. Open Access Emerg Med. 2011;3:69-76doi: 10.2147/OAEM.S24962.
Kalsi, S. S., Wood, D. M., Waring, W. S., & Dargan, P. I. (2011). Does cytochrome P450 liver isoenzyme induction increase the risk of liver toxicity after paracetamol overdose?. Open access emergency medicine : OAEM, 369-76. https://doi.org/10.2147/OAEM.S24962
Kalsi, Sarbjeet S, et al. "Does cytochrome P450 liver isoenzyme induction increase the risk of liver toxicity after paracetamol overdose?." Open access emergency medicine : OAEM vol. 3 (2011): 69-76. doi: https://doi.org/10.2147/OAEM.S24962
Kalsi SS, Wood DM, Waring WS, Dargan PI. Does cytochrome P450 liver isoenzyme induction increase the risk of liver toxicity after paracetamol overdose?. Open Access Emerg Med. 2011 Oct 13;3:69-76. doi: 10.2147/OAEM.S24962. eCollection 2011. PMID: 27147854; PMCID: PMC4753969.
Copy Download .nbib Format: NLM
Essential Tremor.

Current treatment options in neurology

Lambert D, Waters CH.
PMID: 11096690
Curr Treat Options Neurol. 1999 Mar;1(1):6-13. doi: 10.1007/s11940-999-0027-3.

Multiple pharmacologic treatments have been studied, but propranolol and primidone have proven to be the most effective medications. It is unlikely that a patient will respond miraculously to another medication if his or her response to propranolol and primidone...

Cite
Lambert D, Waters CH. Essential Tremor. Curr Treat Options Neurol. 1999;1(1):6-13doi: 10.1007/s11940-999-0027-3.
Lambert, D., & Waters, C. H. (1999). Essential Tremor. Current treatment options in neurology, 1(1), 6-13. https://doi.org/10.1007/s11940-999-0027-3
Lambert, and Waters. "Essential Tremor." Current treatment options in neurology vol. 1,1 (1999): 6-13. doi: https://doi.org/10.1007/s11940-999-0027-3
Lambert D, Waters CH. Essential Tremor. Curr Treat Options Neurol. 1999 Mar;1(1):6-13. doi: 10.1007/s11940-999-0027-3. PMID: 11096690.
Copy Download .nbib Format: NLM
Topiramate Treatment of Essential Tremor in a Patient with Cognitive Deficits.

Case reports in neurology

Leblhuber F, Steiner K.
PMID: 20689627
Case Rep Neurol. 2010 Jan 15;2(1):1-4. doi: 10.1159/000264609.

This case report demonstrates a satisfying response to topiramate in a 79-year-old patient with disabling essential tremor in whom propranolol as well as primidone had to be discontinued due to severe side effects. After 28 months of topiramate treatment,...

Cite
Leblhuber F, Steiner K. Topiramate Treatment of Essential Tremor in a Patient with Cognitive Deficits. Case Rep Neurol. 2010;2(1):1-4doi: 10.1159/000264609.
Leblhuber, F., & Steiner, K. (2010). Topiramate Treatment of Essential Tremor in a Patient with Cognitive Deficits. Case reports in neurology, 2(1), 1-4. https://doi.org/10.1159/000264609
Leblhuber, F, and Steiner, K. "Topiramate Treatment of Essential Tremor in a Patient with Cognitive Deficits." Case reports in neurology vol. 2,1 (2010): 1-4. doi: https://doi.org/10.1159/000264609
Leblhuber F, Steiner K. Topiramate Treatment of Essential Tremor in a Patient with Cognitive Deficits. Case Rep Neurol. 2010 Jan 15;2(1):1-4. doi: 10.1159/000264609. PMID: 20689627; PMCID: PMC2914364.
Copy Download .nbib Format: NLM
Immunosuppressive microenvironment in neuroblastoma.

Frontiers in oncology

Pistoia V, Morandi F, Bianchi G, Pezzolo A, Prigione I, Raffaghello L.
PMID: 23805414
Front Oncol. 2013 Jun 26;3:167. doi: 10.3389/fonc.2013.00167. eCollection 2013.

According to the cancer immunoediting model, the interplay between tumor cells and the host immune system is crucial for the control of tumor growth. NB is a pediatric tumor that presents with metastatic disease at diagnosis in about 50%...

Cite
Pistoia V, Morandi F, Bianchi G, et al. Immunosuppressive microenvironment in neuroblastoma. Front Oncol. 2013;3:167doi: 10.3389/fonc.2013.00167.
Pistoia, V., Morandi, F., Bianchi, G., Pezzolo, A., Prigione, I., & Raffaghello, L. (2013). Immunosuppressive microenvironment in neuroblastoma. Frontiers in oncology, 3167. https://doi.org/10.3389/fonc.2013.00167
Pistoia, Vito, et al. "Immunosuppressive microenvironment in neuroblastoma." Frontiers in oncology vol. 3 (2013): 167. doi: https://doi.org/10.3389/fonc.2013.00167
Pistoia V, Morandi F, Bianchi G, Pezzolo A, Prigione I, Raffaghello L. Immunosuppressive microenvironment in neuroblastoma. Front Oncol. 2013 Jun 26;3:167. doi: 10.3389/fonc.2013.00167. eCollection 2013. PMID: 23805414; PMCID: PMC3693127.
Copy Download .nbib Format: NLM
Treatment of Essential Tremor: Are there Issues We are Overlooking?.

Frontiers in neurology

Louis ED.
PMID: 22275907
Front Neurol. 2012 Jan 13;2:91. doi: 10.3389/fneur.2011.00091. eCollection 2011.

BACKGROUND: Essential tremor (ET) is one of the most common neurological diseases. Although a large number of medications have been tested, there are only two first-line medications, primidone and propranolol, which is a situation that has not changed in...

Cite
Louis ED. Treatment of Essential Tremor: Are there Issues We are Overlooking?. Front Neurol. 2012;2:91doi: 10.3389/fneur.2011.00091.
Louis, E. D. (2011). Treatment of Essential Tremor: Are there Issues We are Overlooking?. Frontiers in neurology, 291. https://doi.org/10.3389/fneur.2011.00091
Louis, Elan D. "Treatment of Essential Tremor: Are there Issues We are Overlooking?." Frontiers in neurology vol. 2 (2011): 91. doi: https://doi.org/10.3389/fneur.2011.00091
Louis ED. Treatment of Essential Tremor: Are there Issues We are Overlooking?. Front Neurol. 2012 Jan 13;2:91. doi: 10.3389/fneur.2011.00091. eCollection 2011. PMID: 22275907; PMCID: PMC3257846.
Copy Download .nbib Format: NLM
A Series of 211 Children with Probable Essential Tremor.

Movement disorders clinical practice

Ghosh D, Brar H, Lhamu U, Rothner AD, Erenberg G.
PMID: 30363473
Mov Disord Clin Pract. 2016 Jul 08;4(2):231-236. doi: 10.1002/mdc3.12385. eCollection 2017.

BACKGROUND: The objective of this study was to characterize the clinical features, course, and treatment of essential tremor (ET) in children.METHODS: A retrospective chart review was conducted over 25 years (1984-2011). Inclusion criteria were age

Cite
Ghosh D, Brar H, Lhamu U, et al. A Series of 211 Children with Probable Essential Tremor. Mov Disord Clin Pract. 2016;4(2):231-236doi: 10.1002/mdc3.12385.
Ghosh, D., Brar, H., Lhamu, U., Rothner, A. D., & Erenberg, G. (2017). A Series of 211 Children with Probable Essential Tremor. Movement disorders clinical practice, 4(2), 231-236. https://doi.org/10.1002/mdc3.12385
Ghosh, Debabrata, et al. "A Series of 211 Children with Probable Essential Tremor." Movement disorders clinical practice vol. 4,2 (2017): 231-236. doi: https://doi.org/10.1002/mdc3.12385
Ghosh D, Brar H, Lhamu U, Rothner AD, Erenberg G. A Series of 211 Children with Probable Essential Tremor. Mov Disord Clin Pract. 2016 Jul 08;4(2):231-236. doi: 10.1002/mdc3.12385. eCollection 2017. PMID: 30363473; PMCID: PMC6174466.
Copy Download .nbib Format: NLM
HLA-B*1502 in Iranian Children with Anticonvulsant Drugs-Induced Skin Reactions.

Iranian journal of child neurology

Tonekaboni SH, Jafari N, Mansouri M, Jabbehdari S, Eftekhari R, Chavoshzadeh Z, Abdollah Gorji F, Mesdaghi M.
PMID: 28698724
Iran J Child Neurol. 2017;11(2):26-30.

OBJECTIVE: Anticonvulsant drugs can cause various forms of skin drug reactions, ranging from exanthema to severe blistering reactions. An association between HLA-B*1502 allele and severe skin reactions have been reported.MATERIALS & METHODS: Fifteen patients with severe skin reactions following...

Cite
Tonekaboni SH, Jafari N, Mansouri M, et al. HLA-B*1502 in Iranian Children with Anticonvulsant Drugs-Induced Skin Reactions. Iran J Child Neurol. 2017;11(2):26-30
Tonekaboni, S. H., Jafari, N., Mansouri, M., Jabbehdari, S., Eftekhari, R., Chavoshzadeh, Z., Abdollah Gorji, F., & Mesdaghi, M. (2017). HLA-B*1502 in Iranian Children with Anticonvulsant Drugs-Induced Skin Reactions. Iranian journal of child neurology, 11(2), 26-30.
Tonekaboni, Seyed Hasan, et al. "HLA-B*1502 in Iranian Children with Anticonvulsant Drugs-Induced Skin Reactions." Iranian journal of child neurology vol. 11,2 (2017): 26-30.
Tonekaboni SH, Jafari N, Mansouri M, Jabbehdari S, Eftekhari R, Chavoshzadeh Z, Abdollah Gorji F, Mesdaghi M. HLA-B*1502 in Iranian Children with Anticonvulsant Drugs-Induced Skin Reactions. Iran J Child Neurol. 2017;11(2):26-30. PMID: 28698724; PMCID: PMC5493826.
Copy Download .nbib Format: NLM
Homozygous mutation in .

Journal of medical genetics

Ravindran E, Gutierrez de Velazco C, Ghazanfar A, Kraemer N, Zaqout S, Waheed A, Hanif M, Mughal S, Prigione A, Li N, Fang X, Hu H, Kaindl AM.
PMID: 34059554
J Med Genet. 2021 May 31; doi: 10.1136/jmedgenet-2020-107518. Epub 2021 May 31.

BACKGROUND: Minichromosomal maintenance (MCM) complex components 2, 4, 5 and 6 have been linked to human disease with phenotypes including microcephaly and intellectual disability. The MCM complex has DNA helicase activity and is thereby important for the initiation and...

Cite
Ravindran E, Gutierrez de Velazco C, Ghazanfar A, et al. Homozygous mutation in . J Med Genet. 2021;doi: 10.1136/jmedgenet-2020-107518.
Ravindran, E., Gutierrez de Velazco, C., Ghazanfar, A., Kraemer, N., Zaqout, S., Waheed, A., Hanif, M., Mughal, S., Prigione, A., Li, N., Fang, X., Hu, H., & Kaindl, A. M. (2021). Homozygous mutation in . Journal of medical genetics, . https://doi.org/10.1136/jmedgenet-2020-107518
Ravindran, Ethiraj, et al. "Homozygous mutation in ." Journal of medical genetics vol. (2021). doi: https://doi.org/10.1136/jmedgenet-2020-107518
Ravindran E, Gutierrez de Velazco C, Ghazanfar A, Kraemer N, Zaqout S, Waheed A, Hanif M, Mughal S, Prigione A, Li N, Fang X, Hu H, Kaindl AM. Homozygous mutation in . J Med Genet. 2021 May 31; doi: 10.1136/jmedgenet-2020-107518. Epub 2021 May 31. PMID: 34059554.
Copy Download .nbib Format: NLM
Risk factors of paradoxical reactions to anti-seizure medication in genetic generalized epilepsy.

Epilepsy research

Gesche J, Hjalgrim H, Rubboli G, Beier CP.
PMID: 33421702
Epilepsy Res. 2021 Feb;170:106547. doi: 10.1016/j.eplepsyres.2020.106547. Epub 2021 Jan 04.

This study aimed at providing valid estimates for the risk of clinically relevant seizure aggravation by recommended anti-seizure medications in patients with Genetic Generalized Epilepsy (GGE). To this aim, treatment response, side effects and paradoxical reactions to anti-seizure treatment...

Cite
Gesche J, Hjalgrim H, Rubboli G, et al. Risk factors of paradoxical reactions to anti-seizure medication in genetic generalized epilepsy. Epilepsy Res. 2021;170:106547doi: 10.1016/j.eplepsyres.2020.106547.
Gesche, J., Hjalgrim, H., Rubboli, G., & Beier, C. P. (2021). Risk factors of paradoxical reactions to anti-seizure medication in genetic generalized epilepsy. Epilepsy research, 170106547. https://doi.org/10.1016/j.eplepsyres.2020.106547
Gesche, Joanna, et al. "Risk factors of paradoxical reactions to anti-seizure medication in genetic generalized epilepsy." Epilepsy research vol. 170 (2021): 106547. doi: https://doi.org/10.1016/j.eplepsyres.2020.106547
Gesche J, Hjalgrim H, Rubboli G, Beier CP. Risk factors of paradoxical reactions to anti-seizure medication in genetic generalized epilepsy. Epilepsy Res. 2021 Feb;170:106547. doi: 10.1016/j.eplepsyres.2020.106547. Epub 2021 Jan 04. PMID: 33421702.
Copy Download .nbib Format: NLM
Assessment of Ethanol-Induced Toxicity on iPSC-Derived Human Neurons Using a Novel High-Throughput Mitochondrial Neuronal Health (MNH) Assay.

Frontiers in cell and developmental biology

Zink A, Conrad J, Telugu NS, Diecke S, Heinz A, Wanker E, Priller J, Prigione A.
PMID: 33224955
Front Cell Dev Biol. 2020 Nov 05;8:590540. doi: 10.3389/fcell.2020.590540. eCollection 2020.

Excessive ethanol exposure can cause mitochondrial and cellular toxicity. In order to discover potential counteracting interventions, it is essential to develop assays capable of capturing the consequences of ethanol exposure in human neurons, and particularly dopaminergic neurons that are...

Cite
Zink A, Conrad J, Telugu NS, et al. Assessment of Ethanol-Induced Toxicity on iPSC-Derived Human Neurons Using a Novel High-Throughput Mitochondrial Neuronal Health (MNH) Assay. Front Cell Dev Biol. 2020;8:590540doi: 10.3389/fcell.2020.590540.
Zink, A., Conrad, J., Telugu, N. S., Diecke, S., Heinz, A., Wanker, E., Priller, J., & Prigione, A. (2020). Assessment of Ethanol-Induced Toxicity on iPSC-Derived Human Neurons Using a Novel High-Throughput Mitochondrial Neuronal Health (MNH) Assay. Frontiers in cell and developmental biology, 8590540. https://doi.org/10.3389/fcell.2020.590540
Zink, Annika, et al. "Assessment of Ethanol-Induced Toxicity on iPSC-Derived Human Neurons Using a Novel High-Throughput Mitochondrial Neuronal Health (MNH) Assay." Frontiers in cell and developmental biology vol. 8 (2020): 590540. doi: https://doi.org/10.3389/fcell.2020.590540
Zink A, Conrad J, Telugu NS, Diecke S, Heinz A, Wanker E, Priller J, Prigione A. Assessment of Ethanol-Induced Toxicity on iPSC-Derived Human Neurons Using a Novel High-Throughput Mitochondrial Neuronal Health (MNH) Assay. Front Cell Dev Biol. 2020 Nov 05;8:590540. doi: 10.3389/fcell.2020.590540. eCollection 2020. PMID: 33224955; PMCID: PMC7674658.
Copy Download .nbib Format: NLM
Hip Fracture Risk in Antiepileptic Drug Initiators and Non-Initiators with Alzheimer's Disease.

Clinical epidemiology

Pisa F, Reinold J, Lavikainen P, Koponen M, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen AM.
PMID: 33911901
Clin Epidemiol. 2021 Apr 22;13:295-307. doi: 10.2147/CLEP.S278306. eCollection 2021.

OBJECTIVE: To determine the risk of hip fracture in persons with Alzheimer´s disease (AD) who initiated antiepileptic drugs (AEDs).METHODS: In the Medication use and AD (MEDALZ) cohort of 70,719 Finnish community dwellers with clinically verified incident AD diagnosis in...

Cite
Pisa F, Reinold J, Lavikainen P, et al. Hip Fracture Risk in Antiepileptic Drug Initiators and Non-Initiators with Alzheimer's Disease. Clin Epidemiol. 2021;13:295-307doi: 10.2147/CLEP.S278306.
Pisa, F., Reinold, J., Lavikainen, P., Koponen, M., Taipale, H., Tanskanen, A., Tiihonen, J., Hartikainen, S., & Tolppanen, A. M. (2021). Hip Fracture Risk in Antiepileptic Drug Initiators and Non-Initiators with Alzheimer's Disease. Clinical epidemiology, 13295-307. https://doi.org/10.2147/CLEP.S278306
Pisa, Federica, et al. "Hip Fracture Risk in Antiepileptic Drug Initiators and Non-Initiators with Alzheimer's Disease." Clinical epidemiology vol. 13 (2021): 295-307. doi: https://doi.org/10.2147/CLEP.S278306
Pisa F, Reinold J, Lavikainen P, Koponen M, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen AM. Hip Fracture Risk in Antiepileptic Drug Initiators and Non-Initiators with Alzheimer's Disease. Clin Epidemiol. 2021 Apr 22;13:295-307. doi: 10.2147/CLEP.S278306. eCollection 2021. PMID: 33911901; PMCID: PMC8075175.
Copy Download .nbib Format: NLM
Photochemical oxidation of PPCPs using a combination of solar irradiation and free available chlorine.

The Science of the total environment

Cheng S, Zhang X, Song W, Pan Y, Lambropoulou D, Zhong Y, Du Y, Nie J, Yang X.
PMID: 31129545
Sci Total Environ. 2019 Sep 10;682:629-638. doi: 10.1016/j.scitotenv.2019.05.184. Epub 2019 May 17.

The degradation of pharmaceuticals and personal care products (PPCPs) by using solar photolysis in the presence of free available chlorine (FAC) was investigated in simulated drinking water. The combination of free available chlorine and sunlight irradiation dramatically accelerated the...

Cite
Cheng S, Zhang X, Song W, et al. Photochemical oxidation of PPCPs using a combination of solar irradiation and free available chlorine. Sci Total Environ. 2019;682:629-638doi: 10.1016/j.scitotenv.2019.05.184.
Cheng, S., Zhang, X., Song, W., Pan, Y., Lambropoulou, D., Zhong, Y., Du, Y., Nie, J., & Yang, X. (2019). Photochemical oxidation of PPCPs using a combination of solar irradiation and free available chlorine. The Science of the total environment, 682629-638. https://doi.org/10.1016/j.scitotenv.2019.05.184
Cheng, Shuangshuang, et al. "Photochemical oxidation of PPCPs using a combination of solar irradiation and free available chlorine." The Science of the total environment vol. 682 (2019): 629-638. doi: https://doi.org/10.1016/j.scitotenv.2019.05.184
Cheng S, Zhang X, Song W, Pan Y, Lambropoulou D, Zhong Y, Du Y, Nie J, Yang X. Photochemical oxidation of PPCPs using a combination of solar irradiation and free available chlorine. Sci Total Environ. 2019 Sep 10;682:629-638. doi: 10.1016/j.scitotenv.2019.05.184. Epub 2019 May 17. PMID: 31129545.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 85 entries